• Megan D. Bailey will step down as executive vice president and president, Central Laboratories and International, effective Sept. 4, 2026.
• Brian J. Caveney, M.D., will take the executive vice president and president, Biopharma Laboratory Services role on Sept. 1, 2026.
• Caveney currently leads Early Development Research Laboratories as executive vice president and president, serving as chief medical and scientific officer.
• Expanded remit includes oversight of Early Development Research Laboratories, Central Laboratories.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000920148-26-000182), on August 14, 2026, and is solely responsible for the information contained therein.